Celiac.com Sponsor (A1):

Celiac.com Sponsor (A1-m):

  • You've found your Celiac Tribe! Join our like-minded, private community and share your story, get encouragement and connect with others.

    💬

    • Sign In
    • Sign Up
  • Jefferson Adams

    Clinical Disease Risk Predictors Better Than SNP-derived Predictors

    Jefferson Adams

    By Jefferson Adams •

    0
    Reviewed and edited by a celiac disease expert.

      Detailed AUROC comparisons reveal that most SNP-derived risk predictions are not as good as clinically based disease risk predictors. 


    Crystal balls. Image: CC BY-ND 2.0--oberbayer
    Caption: Crystal balls. Image: CC BY-ND 2.0--oberbayer

    Celiac.com 01/13/2020 - Numerous genetic studies have identified many highly significant SNPs related to hundreds of diseases or medical conditions. However, very little is known about how GWAS-identified SNPs or combinations of SNP biomarkers can predict the risk for certain diseases, such as celiac disease.

    A team of researchers recently set out to assess the extent to which GWAS-identified SNPs or combinations of SNP biomarkers can predict disease risk.


    Celiac.com Sponsor (A12):




    Celiac.com Sponsor (A12-m):



    The research team included Jonas Patron, Arnau Serra-Cayuela, Beomsoo Han, Carin Li, and David Scott Wishart. They are variously affiliated with the Department of Biological Sciences, University of Alberta, Edmonton, Canada, and the Department of Computing Science, University of Alberta, Edmonton, Canada

    Currently, one of the most common ways researchers gauge the performance of any given predictive biomarker is to calculate the area under the receiver-operator characteristic curve, aka AUROC.

    To create ROC curves and calculate the AUROC using summary-level GWAS data, the team has developed an R package called G-WIZ.

    The team made initial tests of G-WIZ using AUROC values gleaned from patient-level SNP data, as well as reported AUROC numbers. The research team found that G-WIZ predicts the AUROC with greater than 97% accuracy. Next, the team used summary data from GWAS Central to determine the ROC curves and AUROC values for 569 different GWA studies spanning 219 different conditions.

    Armed with this data, the team found a number of GWA studies with SNP-derived risk predictors that have very high AUROCs, above 0.75, while the average GWA study produces a multi-SNP risk predictor with an AUROC of just 0.55.

    Detailed AUROC comparisons reveal that most SNP-derived risk predictions are not as good as clinically based disease risk predictors. Being able to accurately predict risk for certain diseases will help clinicians to better identify patients for potential testing and diagnosis, so knowing the best predictive methods is highly useful information.

    The team’s data, including ROC curves, AUROCs, explained heritability, have been placed in a public database called GWAS-ROCS. 

    Interested parties may download the G-WIZ code for free at github.com.

    Read more at PLOSONE.com

     

     

    0
    Go to articles

    User Feedback

    Recommended Comments

    biokmst

    It is so interesting to also know that certain SNPs will show potential for reactivity in response to additional genetic diseases.  There are Celiac mutations that will show in addition to Hemochromotosis genetic conditions.  It makes sense...Iron overload in addition to anemia conditions.  It's as if a population carries "self-help" as an evolutionary model for survival.  I don't think data models look for this.

     

    Share this comment

    Link to comment
    Share on other sites


    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Restore formatting

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.

    ×

  • Join eNewsletter

  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University, and has authored more than 2,500 articles on celiac disease. His coursework includes studies in science, scientific methodology, biology, anatomy, medicine, logic, and advanced research. He previously served as SF Health News Examiner for Examiner.com, and devised health and medical content for Sharecare.com. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of the book "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):



    Celiac.com Sponsors (A17-m):



  • Related Articles

    Jefferson Adams
    Celiac.com 10/13/2017 - Tissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported as below the reference value (<4 U/mL).
    A team of researchers recently set out to investigate if an undetectable tissue transglutaminase IgA antibodies (tTG IgA<1.2 U/mL) is more predictive of healing compared to patients with negative but detectable serology (1.2-3.9 U/mL).
    The research team included H. Fang, K. S. King, J. J. Larson, M. R. Snyder, T. T. Wu, M. J. Gandhi, and J. A. Murray. They are variously...
    Jefferson Adams
    Celiac.com 11/16/2017 - If people with celiac disease hope to avoid complications, then it's important for their gut mucosa to heal. However, besides biopsy, there is currently no good way for doctors to assess that a patient has healed enough to experience full remission.
    A team of researchers recently set out to assess the role of a point-of-care test (POCT) based on IgA/IgG-deamidated gliadin peptide, in detecting persistent villous atrophy in celiac disease.
    The research team included Michelle S Lau, Peter D Mooney, William L White, Michael A Rees, Simon H Wong, Matthew Kurien, Nick Trott, Daniel A Leffler, Marios Hadjivassiliou and David S...
    Jefferson Adams
    Celiac.com 04/16/2018 - A team of researchers recently set out to investigate whether alterations in the developing intestinal microbiota and immune markers precede celiac disease onset in infants with family risk for the disease.
    The research team included Marta Olivares, Alan W. Walker, Amalia Capilla, Alfonso Benítez-Páez, Francesc Palau, Julian Parkhill, Gemma Castillejo, and Yolanda Sanz. They are variously affiliated with the Microbial Ecology, Nutrition and Health Research Unit, Institute of Agrochemistry and Food Technology, National Research Council (IATA-CSIC), C/Catedrático Agustín Escardin, Paterna, Valencia, Spain; the Gut Health Gro...
    Jefferson Adams
    Celiac.com 08/20/2018 - Following a gluten-free diet is critical for people with celiac disease. However, the factors that influence gluten-free diet success for people with celiac disease are not well understood on a population-wide scale.
    A team of researchers recently set out to assess the factors that influence gluten‐free diet adherence in patients with celiac disease. The research team included E. P. Halmos, M. Deng, S. R. Knowles, K. Sainsbury, B. Mullan, and J. A. Tye‐Din.
    The team asked celiac patients to complete an online survey that included the validated Celiac Dietary Adherence Test, along with questions on demographics, det...